Drug Channels delivers timely analysis and provocative opinions from Adam J. Fein, Ph.D., the country's foremost expert on pharmaceutical economics and the drug distribution system. Drug Channels reaches an engaged, loyal and growing audience of more than 35,000 subscribers. Learn more...

Wednesday, June 16, 2021

EXCLUSIVE: The 340B Program Soared to $38 Billion in 2020—Up 27% vs. 2019

Despite what you may have heard, the 340B Drug Pricing Program continues to thrive.

Discounted purchases under the program reached at least $38 billion in 2020. That figure is an astonishing 27% higher than its 2019 counterpart—and more than quadruple the value of discounted purchases in 2014.

Drug Channels has exclusively obtained the 2020 amount from the Health Resources and Services Administration (HRSA). We received it by filing a Freedom of Information Act (FOIA) request that was just answered yesterday. You can read our FOIA letter below, along with more details on the program's growth.

The 340B program’s size now exceeds the Medicaid program’s outpatient drug sales—and accounts for nearly 20% of the total rebates and discounts that manufacturers provide for brand-name drugs. Alas, many elements of the 340B program—including its controversial contract pharmacy component—lack a comprehensive regulatory infrastructure.

I’ll help you understand what these new figures mean during DCI’s upcoming live video webinar, Drug Channels Update: 340B Controversies and Outlook, on June 25, 2021. Click here to learn more and sign up.

Tuesday, June 15, 2021

Exclusive: 340B Continues Its Unbridled Takeover of Pharmacies and PBMs

Drug Channels Institute’s latest review of contract pharmacies in the 340B Drug Pricing Program reveals that an astonishing 30,000 pharmacy locations—half of the entire U.S. pharmacy industry—now act as contract pharmacies for the hospitals and other healthcare providers that participate in the 340B program.

Over the past 12 months, the number of pharmacies in the program has grown by more than 2,000 locations.

As you will see below, multi-billion-dollar, for-profit, publicly traded pharmacy chains and PBMs—Walgreens, CVS Health, Express Scripts, OptumRx, and Walmart—dominate 340B contract pharmacy relationships with covered entities. 

You can keep your dogecoin and your stonks. The real money lies in the still-booming 340B contract pharmacy business.

I’ll provide more details and crucial context during DCI’s upcoming June 25 live video webinar, Drug Channels Update: 340B Controversies and OutlookClick here to learn more and sign up.

Monday, June 14, 2021

Informa Connect’s 18th Life Sciences Accounting & Reporting Congress

Informa Connect’s 18th Life Sciences Accounting & Reporting Congress
August 10-12, 2021| Virtual Event

The Life Sciences Accounting & Reporting Congress Mid-Year Critical Update provides three comprehensive days of CPE accredited content, showcasing insights and expertise from top finance, accounting, and business leaders from across the life sciences sector. And, attendees are invited to local/regional in-person events for valuable networking and peer-to-peer reconnecting.

Visit www.informaconnect.com/accounting-reporting-congress for further details and to register. Drug Channels readers will save 10% off the current rate when they use promo code 21DRCH10 and register prior to July 9th.*

Join us on August 10-12, 2021 as we delve into complex technical accounting hot topics, high-impact industry trends, deal-making, capital markets forecasts, global risks, technology innovations and more. Expert Keynotes, In-Depth Workshops, Small Group Roundtables and Live Q&A Opportunities position attendees to advance career and company success.

Here’s a snapshot of what to expect:
  • CFO Industry Insights Panel on Forces of Change: R&D, Supply Chain, Digital Transformation and Positioning for Future Success
  • Technical Accounting Deep-Dive, with Benchmarking and Financial Reporting Best Practices
  • SEC and Regulatory Corporate Finance Update
  • Governance Considerations, Audit Committee Hot Topics and Board Composition
  • Leadership Panel on Controllership Innovation
  • Wall Street Discussion on Impactful Deals, Investment Trends and Breakthroughs Impacting the Sector
  • Workshops on:
    • IPO and SPAC Roadmaps
    • Product Launch
    • Corporate Tax and Transfer Pricing
    • ESG Metrics and Disclosures
    • Biotech Acceleration Strategies and Gross-to-Net
    • Valuation Models
    • AI and RPA Applied in Finance
Visit www.informaconnect.com/accounting-reporting-congress for further details and to register. Drug Channels readers will save 10% off the current rate when they use promo code 21DRCH10 and register prior to July 9th.*

*Cannot be combined with other offers or used towards a current registration. Cannot be combined with special category rate or non-profit rates. Other restrictions may apply.

The content of Sponsored Posts does not necessarily reflect the views of Pembroke Consulting, Inc., Drug Channels, or any of its employees.

Friday, June 11, 2021

The Top Five Considerations When Choosing a Patient Solutions Provider

Today’s guest post comes from Jan Nielsen, Division President of AssistRx Patient Solutions.

Jan provides five criteria that manufacturers can use when evaluating the capabilities of a Patient Solutions Provider (PSP), a.k.a. a hub vendor.

To learn more, register for AssistRx's new, four-part webinar series: “Leading the Market in a Rapidly Changing Patient Solutions Landscape.”

Read on for Jan’s insights.

Tuesday, June 08, 2021

Pharmacist Job Market in 2020: Hospital Employment Up, Retail Salaries Down

The Bureau of Labor Statistics (BLS) has recently released its employment and salary data for 2020. That means it’s time to update Drug Channels Institute’s (DCI) annual analysis of pharmacist salaries and employment.

We have found that the share of pharmacists who work at hospitals reached a new high. What’s more, average base salaries for retail pharmacists have dropped, while salaries have risen for pharmacists employed by hospitals, physician offices, and other non-retail settings. 

A word of caution: These data were collected during the peak of last year’s pandemic shutdowns. I suspect that 2020 will turn out to have been a much more challenging year for retail-employed pharmacists.

The 340B Drug pricing Program is a crucial topic for pharmacists. For a deep dive, join me for DCI’s upcoming live video webinar, Drug Channels Update: 340B Controversies and Outlook , on June 25, 2021, from 12:00 p.m. to 1:30 p.m. ET. CLICK HERE TO LEARN MORE AND SIGN UP.

Monday, June 07, 2021

National Association of Specialty Pharmacy (NASP) 2021 Annual Meeting & Expo

National Association of Specialty Pharmacy (NASP) 2021 Annual Meeting & Expo
September 27-30, 2021 | Marriott Marquis, Washington, D.C.
Early Bird Registration Discount Ends June 30.

The National Association of Specialty Pharmacy (NASP) returns to Washington, D.C. on September 27-30 for the National Association of Specialty Pharmacy (NASP) 2021 Annual Meeting & Expo. The 2021 event will welcome attendees to a new conference venue—the beautiful and modern Marriott Marquis, located in the heart of downtown Washington, D.C.

Register today for this premier industry event! Discounted registration rates are available through June 30.

The NASP 2021 Annual Meeting & Expo will challenge and inspire attendees, sponsors, and exhibitors to Reimagine What’s Possible. We will focus on looking at our world differently—reimagining our teams, families, patients, business, the patient journey and ourselves. We will appreciate who we are at our best and understand the power of our presence. Join us to engage in interactive learning, share best practices, explore potential partnerships and synergies, and foster connectivity in a personalized, intimate setting.

The conference agenda is jam packed and offers something for everyone, whether you are new to the industry or a seasoned expert. Conference highlights include:
  • Up to 15 hours of unique CE accredited educational sessions and panel discussions, organized into four dynamic tracks to help you focus on what is most important to you
  • Encore presentations of the most popular sessions
    • Justin Patton, executive coach, will lead the conference in challenging attendees to Reimagine What’s Possible.
    • Monica Pearson, distinguished journalist and humanitarian, and the first woman and first minority to anchor the daily evening news in Atlanta, Georgia.
    • Montel Williams, an Emmy Award winner, decorated former naval officer, inspirational speaker, author, entrepreneur, multiple sclerosis patient, and advocate for patients worldwide.
  • Four pre-conference workshops: the CSP Exam Preparation Course, Legal Day, Technology Day and Hospital/Health Systems Workshop (additional fee required for workshops)
  • Dynamic Exhibit Hall featuring exhibitors representing stakeholders from across the specialty pharmacy industry
  • The ever-popular Women in Specialty Pharmacy Luncheon, featuring motivational keynote speaker Amelia Rose Earhart
  • CE satellite symposia
  • Poster presentations and author discussions
  • NASP Annual Meeting Awards presentations—including three new awards—the Caregiver of the Year award, the Pharmacist of the Year award, and the Pharmacy Technician of the Year award
  • The NASP Ron Bookman Scholarship Awards
  • Direct interaction with industry thought leaders and experts
  • Ample networking opportunities
  • Odyssey Dinner Cruise, an upscale dining and network experience along the Potomac River (additional fee required)
The safety of our guests is NASP’s top priority. We continue to work with federal, state, and local health officials to strictly adhere to current rules and requirements and do everything possible to protect the health and safety of all attendees.

Register today for this important industry event! Discounted registration rates are available through June 30.

The content of Sponsored Posts does not necessarily reflect the views of Pembroke Consulting, Inc., Drug Channels, or any of its employees.

Friday, June 04, 2021

Technology and Human Care Combine to Support the Medication Access Journey

Today’s guest post comes from Nathan Mott, President of CoverMyMeds.

Nathan discusses how technology can augment human expertise to help people access, afford, and adhere to their medications.

To learn more, download CoverMyMeds’ new solutions overview: Technology Helps Drive Medication Access, Adherence and Affordability.

Read on for Nathan’s insights.

Wednesday, June 02, 2021

How CVS Health Drives McKesson’s Distribution Financials

McKesson recently released the annual report for its 2021 fiscal year, which ended on March 31.

The report provides fresh insights about the company’s business with CVS Health, its largest customer. As you will see, CVS purchased $50 billion in pharmaceuticals from McKesson—more than triple the figure from 10 years ago.

The report also reveals that CVS Health paid McKesson in about 24 days, providing the wholesaler with an often-overlooked cash flow benefit. In fact, McKesson’s overall business had a negative cash conversion cycle. That’s essential for a low margin distribution business.

Below, I delve into the financials behind these two elements of the McKesson-CVS relationship. You’ll understand why CVS is McKesson’s worst best friend.

Join me for DCI’s upcoming live video webinar, Drug Channels Update: 340B Controversies and Outlook , on June 25, 2021, from 12:00 p.m. to 1:30 p.m. ET. CLICK HERE TO LEARN MORE AND SIGN UP.

Tuesday, June 01, 2021

NEW: Drug Channels Update: 340B Controversies and Outlook (live video webinar)

Dr. Adam J. Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels, invites you to join him for his latest live video webinar:

Friday, June 25, 2021 (12:00 p.m. to 1:30 p.m. ET)

This event is part of The Drug Channels 2021 Quarterly Video Webinar Series. Anyone who registered for the entire series will receive an email with a link to access the June event.


Dr. Fein will help you and your team stay on top of the current trends and market developments. During the June 25 event, Dr. Fein will focus on the latest developments regarding contract pharmacies in the 340B Drug Pricing Program, including:
  • Evolution of the 340B program
  • Our 2021 analysis of the 340B contract pharmacy market
  • The flow of funds in a 340B contract pharmacy network
  • How 340B impacts payers, plan sponsors, and PBMs
  • How 340B disrupts manufacturer-PBM rebates
  • Current program administration controversies
  • The latest manufacturer actions and covered entity responses
  • How to make sense of ongoing litigation
  • Policy options and actions
  • Possible resolutions to the contract pharmacy conflict
  • And more!
PLUS: During the webinar, Dr. Fein will give participants an opportunity to unmute themselves and ask live questions. The webinar will be 90 minutes to accommodate audience questions.

The 340B Drug Pricing Program remains highly controversial. As always, Dr. Fein will clearly distinguish his opinions and interpretations from the objective facts and data.

Read on for full details on pricing and registration. You can also watch a brief video invitation.

Tuesday, May 25, 2021

Drug Channels News Roundup, May 2021: 340B & PBMs, Benefit Design Problems, Overworked Pharmacists, Hospitals Keep Grabbing Physicians, and New Patent Games

Summer unofficially begins this weekend! Let’s turn up the heat with these sizzling news bites straight from the Drug Channels grill:
  • Cardinal Health delivers fresh evidence of PBM profiteering from 340B contract pharmacies
  • Pharma critics dare to acknowledge that benefit designs actually matter
  • Pharmacists at retail chains are really stressed out
  • Hospitals’ takeover of the physician market continues
Plus, more troubling patent news for owners of intellectual property.

P.S. Join the nearly 11,800 followers of my daily links to neat stuff at @DrugChannels on Twitter. You can also follow me on LinkedIn.

Friday, May 21, 2021

Six Trends to Watch in the New Healthcare Economy

Today’s guest post comes from Karen Eckert, Senior Manager of Commercial Support for Clinical Effectiveness at Wolters Kluwer, Health. She also serves as co-chair of Maintenance and Control at the NCPDP.

Karen examines trends in drug development, pricing, and healthcare. She explains how coordinated intelligence can help businesses improve effectiveness in the new healthcare economy.

To learn more, download Six trends and tactics to thrive in the new healthcare economy, a free white paper from Wolters Kluwer.

Read on for Karen’s insights.

Tuesday, May 18, 2021

The Specialty Pharmacy Accreditation Boom Slows: DCI’s Exclusive Update on the U.S. Market

It’s time for Drug Channels Institute’s annual update of the number of U.S. specialty pharmacies. Fortunately, I had outstanding research assistance. (See photo at right.)

As you will note below, the specialty pharmacy industry remains quite diverse—despite the concentration of dispensing revenues within a small number of companies.

Our proprietary analyses have identified more than 1,200 locations that have achieved specialty pharmacy accreditation from one of the two major independent accreditation organizations. 

Overall accreditation growth appears to be slowing. However, pharmacy locations owned by healthcare providers—hospitals, health systems, physician practices, and providers’ group purchasing organizations—now account for nearly 40% of all accredited specialty pharmacy locations.

Read on for a bite of our arithmomania.